Paolo Fundarò

Founder at

Xgen Venture Sgr SpA

52 year

72 connections

Health Technology

Finance

Communications

Profile

Before co-founding XGEN in2021, Paolo was in Genextra since its inception, serving as CEO up to 2022.
Paolo is also board member and co-investor of a number of Genextra companies including Targimmune Therapeutics and Erydel; he is board member and Chairman of Intercept Pharmaceutical (NADAQ: ICPT) since 2006.
Prior to Genextra, he acquired several start-up experiences, including e.Biscom/Fastweb (2000-2004), and investment banking in London.
Paolo is co-founder of Italian Angels for Biotech (IAB).
He holds a cum laude degree in B.A. & Finance from Bocconi University.

Paolo Fundarò active positions

Companies	Position	Start
EryDel SpA EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases	Director/Board Member	01/01/2013
Applango Systems Ltd. Applango Systems Ltd. Packaged SoftwareTechnology Services Provides software tools for enterprise organizations	Director/Board Member	01/01/2012
Applango USA, Inc. Applango USA, Inc. Packaged SoftwareTechnology Services Develops salesforce application	Director/Board Member	01/01/2013
InnovHeart Srl InnovHeart Srl Medical SpecialtiesHealth Technology Manufactures and commercializes medical devices	Director/Board Member	01/12/2015
Targimmune Therapeutics AG Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies	Director/Board Member	01/06/2020
Xgen Venture Sgr SpA Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions.	Founder	01/06/2021

All active positions of Paolo Fundarò

Former positions of Paolo Fundarò

Companies	Position	End
INTERCEPT PHARMACEUTICALS, INC.	Chairman	08/11/2023
Genextra SpA Genextra SpA Investment ManagersFinance Genextra invest in companies located Italy. The firm focuses on the life science companies. It participates in early stage capital transactions.	Chief Executive Officer	01/07/2022
TESSELLIS S.P.A.	Director/Board Member	17/05/2022
░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░

See the detail of Paolo Fundarò's experience

Training of Paolo Fundarò

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paolo Fundarò's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Credit Suisse (USA) LLC Credit Suisse (USA) LLC Investment Banks/BrokersFinance Provides investment banking and asset management services	Finance
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
Congenia Srl Congenia Srl Miscellaneous Commercial ServicesCommercial Services Develops and produces molecular drugs and pharmaceutical products	Commercial Services
Tessellis SpA Tessellis SpA Major TelecommunicationsCommunications Operates as a holding company whose subsidiaries provides internet access, telephony and multimedia services	Communications
Fastweb SpA Fastweb SpA Major TelecommunicationsCommunications Provides fiber broadband carrier services	Communications
University of Bocconi University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Salomon Smith Barney International Ltd. Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Security Broker	Finance
Genextra SpA Genextra SpA Investment ManagersFinance Genextra invest in companies located Italy. The firm focuses on the life science companies. It participates in early stage capital transactions.	Finance
EryDel SpA EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases	Health Technology
Tethis SpA Tethis SpA BiotechnologyHealth Technology Develops liquid biopsy platforms and AI-assisted diagnostic solutions for cancer detection and precision medicine	Health Technology
Applango USA, Inc. Applango USA, Inc. Packaged SoftwareTechnology Services Develops salesforce application	Technology Services
Applango Systems Ltd. Applango Systems Ltd. Packaged SoftwareTechnology Services Provides software tools for enterprise organizations	Technology Services
Genenta Science SpA Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors	Health Technology
Targimmune Therapeutics AG Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies	Health Technology
Dac SRL Dac SRL Motor VehiclesConsumer Durables Manufactures and sells car, bike, motorbike accessories and spare parts	Consumer Durables
InnovHeart Srl InnovHeart Srl Medical SpecialtiesHealth Technology Manufactures and commercializes medical devices	Health Technology
Xgen Venture Sgr SpA Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions.	Finance